Maintenance of normal blood glucose level
Forminol® is a cutting-edge food supplement developed through a rigorous 4-year R&D project, specifically designed to support diabetes treatment. It is particularly beneficial for individuals with type II diabetes and prediabetic patients, including those on metformin therapy.
Forminol®
Food supplement
30 HPMC delayed release capsules
Forminol® represents a holistic approach to managing diabetes, offering not only glycemic control but also cardiovascular and metabolic benefits. It is Ready-to-Market product and ideal for B2B clients seeking to expand their portfolio with a scientifically validated, innovative product that supports diabetes management.
Key Features:
Unique Composition
Forminol® includes the AP029 blend, a proprietary mix of elderberry, aronia, and blackcurrant extracts standardized for anthocyanins. These ingredients are known for their antioxidant properties and their ability to support glucose metabolism and lipid regulation.
Clinically Proven
Extensive clinical trials have demonstrated Forminol®'s effectiveness in enhancing glucose uptake, reducing blood glucose and insulin levels, and improving lipid metabolism. The AP029 blend shows a synergistic effect with metformin, further enhancing its benefits.
Patent-Pending Formula
The innovative composition of Forminol® is protected under a pending patent (Patent Application No. P.444522), underscoring its uniqueness and effectiveness.
Additional Benefits
Forminol® helps lower IL-6 and CRP levels, which are inflammatory markers associated with diabetes, and increases the activity of superoxide dismutase (SOD), an important antioxidant enzyme.
Convenient Dosage Forms
Available in DRcaps® capsules, which protect the ingredients from stomach acids and ensure their release in the intestine for optimal absorption.
Clinical Study Highlights:
Participants experienced significant improvements in glucose metabolism indicators and lipid profiles.
Forminol® effectively reduced HbA1c levels, increased HDL, and decreased LDL cholesterol.
Users reported a natural reduction in appetite and fewer gastrointestinal side effects compared to the placebo group.